Driving reinvestment in R&D for antibiotics and advocating their responsible use

News

UK Review on Antimicrobial Resistance calls for wider use of vaccines & alternative approaches to drug-resistant infections

The UK Review on Antimicrobial Resistance, chaired by Jim O’Neill, released its latest report on February 11 2016, titled “Vaccines and alternative approaches: reducing our dependence on antimicrobials“. This latest in a series of reports by the Review on Antimicrobial Resistance sets out that there are too few vaccines and alternative approaches to antibiotics available for doctors to use to tackle many of our most urgent drug resistance threats, and that there is a need for further investment in the development of these products. The report provides an overview of the markets and the pipelines for...
Read more

DRIVE-AB Participant Stefan Peterson appointed Chief of Health at UNICEF, New York

Stefan Swartling Peterson, Professor of Global Health at the Department of Women’s and Children’s Health at Uppsala University in Sweden and active DRIVE-AB participant in Work Package 2 (Creation and testing of new economic models), has been appointed the Chief of Health at UNICEF in New York starting from the middle of February. Prof Peterson may be moving to New York, but this will not stop him from continuing his important contributions to DRIVE-AB. To read more about Prof Peterson and his new appointment, please click here.    ...
Read more

DRIVE-AB is organizing high-level conference to identify and evaluate feasible reward models

The consortium is organizing a high-level conference to bring together policy makers, regulatory and public health experts, and economists to identify and evaluate reward models that are feasible, practical and can be implemented globally. This event is expected to stimulate a dialogue among international decision-makers on the implementation of R&D incentive policies which will help to inform DRIVE-AB final recommendations, which will be announced in 2017. For more information, please view the event page....
Read more

Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance

On January 21, 2016, the Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance was launched at an event at the World Economic Forum in Davos, Switzerland. This was drafted, agreed and signed by 85 companies and nine industry associations from across the global pharmaceutical, diagnostics and biotechnology industries in 18 different countries. In the Declaration, signatory companies call on governments to work with them to develop new and alternative market structures that provide more dependable and sustainable market models for antibiotics, and to commit the funds needed to implement them. The Declaration on Combating Antimicrobial Resistance represents a major milestone in...
Read more

DRIVE-AB reports on solutions from other industries applicable to the antibiotic field

Work Package 2, responsible for the creation and testing of new economic models, has released a short report on solutions from other industries that are applicable to the antibiotic field. The report is an assessment of reward and business models in other industries that promote conservation and that address key challenges that are similar to those faced in the field of antibiotics. To read the report, please click here. To see more about Work Package 2 and their outputs, please click here. To view all DRIVE-AB outputs, please click here.  ...
Read more